Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Trial
Headache The Journal of Head and Face Pain2019Vol. 59(8), pp. 1240–1252
Citations Over TimeTop 1% of 2019 papers
David Yarnitsky, David W. Dodick, Brian M. Grosberg, Rami Burstein, Alon Ironi, Dagan Harris, Tamar Lin, Stephen D. Silberstein
Abstract
REN provides superior clinically meaningful relief of migraine pain and MBS compared to placebo, offering a safe and effective non-pharmacological alternative for acute migraine treatment.
Related Papers
- → A randomized double blind placebo controlled trial to assess the safety and efficacy of a patented fenugreek (Trigonella foenum-graecum) seed extract in Type 2 diabetics(2024)6 cited
- [Double-blind placebo-controlled cow's milk challenge for children in general hospitals].(2006)
- Recurrence of symptoms after a negative double-blind, placebo-controlled food challenge: false positive re-introduction or false negative double-blind, placebo-controlled food challenge?(2012)
- → Decision letter for "A high potency multi‐strain probiotic improves glycemic control in children with new‐onset Type 1 diabetes mellitus: a randomized, double‐blind, placebo‐controlled pilot study"(2021)
- → Comments on the article “Comparing the efficacy of continuous and pulsed ultrasound therapies in patients with lateral epicondylitis: A double-blind, randomized, placebo-controlled study”(2021)